title: Varenicline impairs extinction and enhances reinstatement across repeated cycles of nicotine self-administration in rats.
abstract: Varenicline is a partial nicotine receptor agonist widely prescribed as a smoking cessation medication. Repeated (or long-term) use of varenicline has been proposed as a treatment option for tobacco addiction. However the effect of repeated varenicline use on motivation for nicotine is unknown. Here the intravenous nicotine self-administration paradigm in rats was used to model the consequences of varenicline treatment across repeated cycles of administration, extinction and reinstatement. Rats acquired nicotine self-administration across 20 days before undergoing 6 days of extinction, where each extinction session was preceded by a single injection of varenicline or saline. This was followed by a single varenicline-free nicotine-primed reinstatement test. All rats then reacquired nicotine self-administration for 10 days followed by a second cycle of extinction. Across this period, rats either received a second cycle of varenicline (VAR-VAR) or saline (SAL-SAL), or the alternative treatment (SAL-VAR, VAR-SAL), followed by a final reinstatement test. Treatment with varenicline increased responding across the first cycle of extinction, but did not affect responding in the reinstatement test. Across the second cycle, varenicline again increased responding across extinction, and critically, rats treated with varenicline across cycle 1 and saline across cycle 2 (Group VAR-SAL) exhibited more reinstatement than rats in any other group. The effect of VAR on nicotine seeking was not due to its effects on locomotor activity. Instead, the results suggest that a history of VAR can increase vulnerability to reinstatement/relapse when its treatment is discontinued. The possible mechanisms of this increased vulnerability are discussed.
authors.affiliation: School of Psychology, University of New South Wales, Sydney, Australia.
authors.forename: Claire L
authors.initials: CL
authors.lastname: Macnamara
authors.affiliation: School of Psychology, University of New South Wales, Sydney, Australia.
authors.forename: Nathan M
authors.initials: NM
authors.lastname: Holmes
authors.affiliation: School of Psychology, University of New South Wales, Sydney, Australia.
authors.forename: R Fred
authors.initials: RF
authors.lastname: Westbrook
authors.affiliation: School of Psychology, University of New South Wales, Sydney, Australia. Electronic address: k.clemens@unsw.edu.au.
authors.forename: Kelly J
authors.initials: KJ
authors.lastname: Clemens
mesh_terms: D000818:Animals; D002408:Catheters, Indwelling; D004195:Disease Models, Animal; D058999:Drug-Seeking Behavior / Q000187:drug effects*; D005108:Extinction, Psychological / Q000187:drug effects*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000008:administration & dosage*; D018722:Nicotinic Agonists / Q000008:administration & dosage*; D017207:Rats, Sprague-Dawley; D012646:Self Administration; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000188:drug therapy* / Q000191:economics*; D000068580:Varenicline / Q000494:pharmacology*
chemical_list: D018722:Nicotinic Agonists; D009538:Nicotine; D000068580:Varenicline
keywords: Extinction; Nicotine; Rat; Reinstatement; Self-administration; Varenicline